<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Yin H</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Adult T-cell acute lymphoblastic leukemia (T-ALL) is a heterogeneous malignant tumor with poor prognosis. However, accurate prognostic stratification factors are still unclear.&lt;h4>Methods&lt;/h4>Data from 90 adult T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) patients were collected. The association of gene mutations detected by next-generation sequencing and clinical characteristics with the outcomes of T-ALL/LBL patients were retrospectively analyzed to build three novel risk stratification models through Cox proportional hazards model.&lt;h4>Results&lt;/h4>Forty-seven mutated genes were identified. Here, 73.3% of patients had at least one mutation, and 36.7% had ≥3 mutations. The genes with higher mutation frequency were &lt;i>NOTCH1&lt;/i>, &lt;i>FBXW7&lt;/i>, and &lt;i>DNMT3A&lt;/i</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>811151</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8908046</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing.</pubmed_title><pmcid>PMC8908046</pmcid><pubmed_authors>Yao L</pubmed_authors><pubmed_authors>Yin H</pubmed_authors><pubmed_authors>Hong M</pubmed_authors><pubmed_authors>Qian C</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Wu Q</pubmed_authors><pubmed_authors>Deng J</pubmed_authors><pubmed_authors>Teng Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing.</name><description>&lt;h4>Background&lt;/h4>Adult T-cell acute lymphoblastic leukemia (T-ALL) is a heterogeneous malignant tumor with poor prognosis. However, accurate prognostic stratification factors are still unclear.&lt;h4>Methods&lt;/h4>Data from 90 adult T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) patients were collected. The association of gene mutations detected by next-generation sequencing and clinical characteristics with the outcomes of T-ALL/LBL patients were retrospectively analyzed to build three novel risk stratification models through Cox proportional hazards model.&lt;h4>Results&lt;/h4>Forty-seven mutated genes were identified. Here, 73.3% of patients had at least one mutation, and 36.7% had ≥3 mutations. The genes with higher mutation frequency were &lt;i>NOTCH1&lt;/i>, &lt;i>FBXW7&lt;/i>, and &lt;i>DNMT3A&lt;/i</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T21:48:10.018Z</modification><creation>2025-04-19T21:48:10.018Z</creation></dates><accession>S-EPMC8908046</accession><cross_references><pubmed>35280829</pubmed><doi>10.3389/fonc.2022.811151</doi></cross_references></HashMap>